Defending Medication Abortion - Reproductive Freedom for All

Defending Medication Abortion

Image of a large group of protesters on the Dobbs anniversary, marching down a street in Washington, DC, with banners and signs, including one that says, “Our bodies, Our lives, Our decisions, Our Court.

Above: Protesters on the the anniversary of Dobbs v. Jackson Women’s Health Organization anniversary, marching down a street in Washington DC.

Not even a year after Roe v. Wade was overturned, in spring 2023 we saw another federal case threatening abortion access. Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration (FDA) challenged the FDA’s approval of mifepristone—a vital pill used in medication abortion care.

For months, this case made its way through the courts, resulting in widespread confusion for patients and providers. And in December 2023, the Supreme Court decided to weigh in—giving the justices an opportunity to roll back abortion access in our country even further.

Update: The U.S. Supreme Court ruled on June 13, 2024, to not restrict mifepristone. While this is a relief, this baseless case should have never made it this far. Anti-abortion extremists worked for decades to overturn Roe—and they will keep chipping away at medication abortion and every single one of our other fundamental freedoms unless we stop them.

Mifepristone is:

Mifepristone is typically used in the most common method of abortion in this country

Mifepristone is safer than Tylenol

Mifepristone is less expensive than other methods of abortion care

Mifepristone is more accessible for people who don't have access to in-person care


 

In response to this case, and other threats to medication abortion care, Reproductive Freedom for All:

Partnered with ACLU Reproductive Freedom Project and Planned Parenthood Action Fund to create a communications war room, pushing accurate information and messaging.

SPOTLIGHT

Polling from Kaiser Family Foundation in May 2023 revealed that “Awareness of mifepristone...has doubled since January 2023.”

Published research to drive the conversation about medication abortion, including:

A memo revealing that 64.5 million women of reproductive age would lose access to medication abortion care if mifepristone were pulled off the market. We landed an exclusive story about our research report in Axios and reached 109 million people overall through media coverage.

A report unveiling that Alliance for Hippocratic Medicine is nothing more than a coalition of right-wing organizations cooked up to push for a national ban on medication abortion.

Trained our members to host community dialogues,

helping them engage with friends and family about medication abortion. After our March training, members hosted 12 community dialogues—two of which were youth-led. They engaged over 100 people.

Leveraged our social media

to raise awareness and educate our followers about what mifepristone is and what this latest threat means for access. Check out our Instagram to learn more.

Mobilized our members to sign the People’s Petition,

urging the courts to uphold the law. Reproductive Freedom for All gathered 15,490 signatures.

Keep up with this case

ReproForAll.Org/MIFE

  Reproductive Freedom for All Logo    

  Reproductive Freedom for All Foundation Logo    


 

Repro For All at SCOTUS rally

Stay In the Know

Opponents of reproductive freedom move fast—and so do you.

Sign up to receive updates and information on how to take action with us.